Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer

NCT03323346 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm Female
Metastatic Breast Cancer

Interventions

DRUG: Disulfiram

Sponsor

The Institute of Molecular and Translational Medicine, Czech Republic

Collaborators

[object Object]